3: Initial statement of beneficial ownership of securities
Published on October 5, 2006
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIESFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 09/27/2006 |
3. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
|---|---|---|---|
| Common Stock | 391 | D |
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
|---|---|---|---|---|---|---|---|
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Incentive Stock Option (right to buy) | (1) | 03/10/2013 | Common Stock | 10,000 | 36.05 | D | |
| Incentive Stock Option (right to buy) | (2) | 02/04/2014 | Common Stock | 3,492 | 50.9 | D | |
| Incentive Stock Option (right to buy) | (3) | 02/02/2015 | Common Stock | 1,890 | 57.31 | D | |
| Incentive Stock Option (right to buy) | (4) | 02/13/2013 | Common Stock | 864 | 76.67 | D | |
| Non-Qualified Stock Option (right to buy) | (2) | 02/04/2014 | Common Stock | 3,008 | 50.9 | D | |
| Non-Qualified Stock Option (right to buy) | (3) | 02/02/2015 | Common Stock | 4,610 | 57.31 | D | |
| Non-Qualified Stock Option (right to buy) | (4) | 02/13/2013 | Common Stock | 1,799 | 76.67 | D | |
| Restricted Stock Unit | (5) | (5) | Common Stock | 664 | (5) | D | |
| Explanation of Responses: |
| 1. Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (3/10/2004) of the date of grant. |
| 2. Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (2/05/2005) of the date of grant. |
| 3. Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (02/03/2006) of the date of grant. |
| 4. Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on 02/14/2007. |
| 5. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. Common Stock. The restricted stock units vest in five equal annual installments beginning on February 14, 2007. |
| Conan R. Deady, Attorney-in-Fact for Thomas J. Dupree | 10/05/2006 | |
| ** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.